Deccan Health Care Limited has submitted a regulatory intimation to the Listing Compliance Department of BSE Limited regarding an upcoming board meeting.
Nature of Disclosure: This is a mandatory disclosure made pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Board Meeting Details: The meeting of the Board of Directors is scheduled to be held on Friday, 13th November 2026. The primary agenda is to consider and approve the Un-audited Financial Results (both Standalone and Consolidated) for the quarter and half year ended September 30th, 2026.
Trading Window Closure: In accordance with the Company's Code of Conduct for Prevention of Insider Trading, the trading window for dealing in the company's securities was closed for Designated Persons, their immediate relatives, and other Insiders effective October 01, 2026. This closure was previously intimated to relevant parties via a letter dated September 25, 2026. The trading window will reopen 48 hours after the declaration of the Financial Results.
Financial Impact: The financial impact of the results to be considered is not quantified in this disclosure, as this is solely a meeting intimation.